Alex Blyth

Company: LiFT Biosciences

Job title: Chief Executive Officer

Seminars:

PANEL DISCUSSION: Leveraging Different Innate Cell Types for Therapeutic Efficacy in Oncology & Beyond 3:00 pm

With significant work taking place to understand the potential of novel innate cell types such as macrophages, neutrophils and iNKT cells for treatment applications in Oncology, attention also turns to the therapeutic application of innate cells for other important diseases such as inflammatory, autoimmune and fibrosis indications. This panel discussion will cover: Understanding the key…Read more

day: Conference Day Two

Case Study: Utilising Immunomodulatory Alpha Neutrophils to Promote Solid Tumour Infiltration 1:00 pm

Exploiting chemokine signalling to promote solid tumour infiltration Reprogramming immunosuppressive TME to recruit a wider immune response via favourable cytokine production Engaging the adaptive immune system through upregulatiuon of 4-1BB and OX-40 to promote persistanceRead more

day: Conference Day Two